Addus HomeCare (ADUS) to Release Quarterly Earnings on Monday

Addus HomeCare (NASDAQ:ADUS) will likely be announcing its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of $1.35 per share and revenue of $291.04 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $109.23 on Friday. The stock has a market capitalization of $1.98 billion, a price-to-earnings ratio of 25.00, a PEG ratio of 1.46 and a beta of 1.00. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.72. The stock’s 50 day moving average price is $125.04 and its two-hundred day moving average price is $126.75.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ADUS shares. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Oppenheimer increased their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Stephens raised their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Finally, Macquarie restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $134.22.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is owned by corporate insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.